ArticleHuman vaccines & immunotherapeutics2021

Effectiveness of palivizumab in preventing respiratory syncytial virus infection in high-risk children.

Natividad Viguria et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.